FIELD: organic chemistry. SUBSTANCE: reaction conditions: process is carried out in the presence of acid; active form is used if optically active form of the end product is synthesized. Synthesized compounds were used in medicine as an inhibitor of thromboxane synthase catalyzing formation of arachidonic acid metabolite, and thromboxane-antagonists, for treatment of ischemic heart disease, cerebro-vascular disease system or/and inflammation. EFFECT: improved method of synthesis. 2 tbl
Authors
Dates
1995-10-10—Published
1989-10-20—Filed